DescriptionTilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 12.35 +1.05% increase |
| 15.68 -20.41% decrease |
| -2.97 (-19.22%) decrease |
|3-Month|| 12.35 +1.05% increase |
| 20.69 -39.68% decrease |
| -5.06 (-28.85%) decrease |
|52-Week|| 12.35 +1.05% increase |
| 27.88 -55.24% decrease |
| N/A (N/A) no change |